← Eichor
Study identifier: NCT03267615 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

VICIS - Vienna Cirrhosis Study

Condition: Liver Cirrhosis · Portal Hypertension · Ascites  ·  Sponsor: Medical University of Vienna

PhaseN/A
Planned participants10000
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

Patients with advanced chronic liver diseases treated at the Vienna General Hospital of the Medical University of Vienna will be offered to participate in this prospective observational trial - including an optional participation in a biobank. Clinical parameters and laboratory parameters will be recorded for all patients and patients will undergo a regular follow-up schedule with clinical visits at the Vienna General Hospital. This study is linked to a biobank with serum/plasma, ascitic fluid, urine, GI tract mucosal biopsies, liver biopsies and stool collected from the study participants.

This description comes directly from the study's public registry record.

Talk to the study team

Thomas Reiberger, M.D.  ·  +43140400  ·  thomas.reiberger@meduniwien.ac.at

Mattias Mandorer, M.D.  ·  +43140400  ·  mattias.mandorfer@meduniwien.ac.at

Always discuss trial participation with your own doctor first.

Locations (1)

Medical University of ViennaVienna, AustriaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03267615